Scientific Reports · 2016 · 67 citations · 20 references
MedicineMolecular BiologyOncologyGene ExpressionGene Expression AnalysisMolecular OncologyCancer EpigeneticsCancer EpigenomicsCancer GenomicsEpigenetic Alterations In CancerEpigenetic BiomarkersNoncoding Rna In CancerCancer Epigenetic BiomarkersDifferential Transcript ExpressionLong Non-coding Ribonucleic AcidsLong Non-coding Rna BiomarkersMicroarray AnalysisNon-coding Rna BiomarkersNon-coding Rna ProfilingNoncoding Rna Expression Profiling
To identify what long non-coding RNAs (lncRNAs) are involved in non-small cell lung cancer (NSCLC), we analyzed microarray data on gene expression and methylation. Gene expression chip and HumanMethylation450BeadChip were used to interrogate genome-wide expression and methylation in tumor samples. Differential expression and methylation were analyzed through comparing tumors with adjacent non-tumor tissues. LncRNAs expressed differentially and correlated with coding genes and DNA methylation were validated in additional tumor samples using RT-qPCR and pyrosequencing. In vitro experiments were performed to evaluate lncRNA's effects on tumor cells. We identified 8,500 lncRNAs expressed differentially between tumor and non-tumor tissues, of which 1,504 were correlated with mRNA expression. Two of the lncRNAs, LOC146880 and ENST00000439577, were positively correlated with expression of two cancer-related genes, KPNA2 and RCC2, respectively. High expression of LOC146880 and ENST00000439577 were also associated with poor survival. Analysis of lncRNA expression in relation to DNA methylation showed that LOC146880 expression was down-regulated by DNA methylation in its promoter. Lowering the expression of LOC146880 or ENST00000439577 in tumor cells could inhibit cell proliferation, invasion and migration. Analysis of microarray data on gene expression and methylation allows us to identify two lncRNAs, LOC146880 and ENST00000439577, which may promote the progression of NSCLC.
20
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations
MiR-195 suppresses non-small cell lung cancer by targeting CHEK1
Ben Liu, Jinli Qu, Fangxiu Xu et al. · Oncotarget · 2015 · 159 citations · Full text
Medicine, Cancer Biology, Oncology +16